Publications

2024

  • Bangert C, Alkon N, Chennareddy S, Arnoldner T, Levine JP, Pilz M, Medjimorec MA, Ruggiero J, Cohenour ER, Jonak C, Damsky W, Griss J, Brunner PM: “Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells.” Nat Commun. 2024 Apr 2;15(1):2839. doi: 10.1038/s41467-024-46540-0.
  • Tran SS, Ungar B, Brunner PM. “Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream.” JAAD Case Rep. 2024 Mar 6;47:1-3. doi: 10.1016/j.jdcr.2024.02.022. eCollection 2024 May
  • Chang YT, Prompsy P, Kimeswenger S, Tsai YC, Ignatova D, Pavlova O, Iselin C, French LE, Levesque MP, Kuonen F, Bobrowicz M, Brunner PM, Pascolo S, Hoetzenecker W, Guenova E.: “MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides.” Nat Commun. 2024 Jan 25;15(1):752. doi: 10.1038/s41467-024-45083-8.

2023

  • Schmid-Grendelmeier P, Gooderham MJ, Hartmann K, Konstantinou GN, Fellmann M, Koulias C, Clibborn C, Biswas P, Brunner PM.: „Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies.“ Allergy. 2023 Nov 21. doi: 10.1111/all.15952. Online ahead of print
  • O’Hagan R, Caldas SA, Brunner PM, Ungar B.: “A Survey of Patient Demographics in Inflammatory Skin Disease Case Reports.” JMIR Dermatol. 2023 Sep 25;6:e49070. doi: 10.2196/49070.
  • Piaserico S, Riedl E, Pavlovsky L, Vender RB, Mert C, Tangsirisap N, Haustrup N, Gallo G, Schuster C, Brunner PM. „Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO).“ Front Med (Lausanne). 2023 Jun 29;10:1185523. doi: 10.3389/fmed.2023.1185523. eCollection 2023.
  • Mitamura Y, Reiger M, Kim J, Xiao Y, Zhakparov D, Tan G, Rückert B, Rinaldi AO, Baerenfaller K, Akdis M, Brüggen MC, Nadeau KC, Brunner PM, Roqueiro D, Traidl-Hoffmann C, Akdis CA. “Spatial transcriptomics combined with single-cell RNA-sequencing unravels the complex inflammatory cell network in atopic dermatitis.” Allergy. 2023 Jun 14. doi: 10.1111/all.15781. Online ahead of print.
  • Alkon N, Assen FP, Arnoldner T, Bauer WM, Medjimorec MA, Shaw L, Rindler K, Holzer G, Weber P, Weninger W, Freistätter C, Chennareddy S, Kinaciyan T, Farlik M, Jonak C, Griss J, Bangert C, Brunner PM: “Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis”, J Allergy Clin Immunol 2023. Online ahead of print.
  • Rindler K, Tschandl P, Levine JP, Shaw LE, Weninger W, Farlik M, Jonak C, Brunner PM: “Single-cell RNA sequencing analysis of a COVID-19-associated maculopapular rash in a patient with psoriasis treated with ustekinumab.” J Dermatol. 2023 Apr 1. doi: 10.1111/1346-8138.16793. Online ahead of print.

2022

  • Rauer L, Reiger M, Bhattacharyya M, Brunner PM, Krueger JG, Guttman-Yassky E, Traidl-Hoffmann C, Neumann AU.: “Skin microbiome and its association with host cofactors in determining atopic dermatitis severity.” J Eur Acad Dermatol Venereol. 2022 Nov 25. doi: 10.1111/jdv.18776. Online ahead of print.
  • Blauvelt A, Boguniewicz M, Brunner PM, Luna PC, Biswas P, DiBonaventura M, Farooqui SA, Rojo R, Cameron MC: “Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life.” J Dermatolog Treat. 2022 Aug;33(5):2605-2613. doi: 10.1080/09546634.2022.2059053.
  • Quint T, Dahm V, Ramazanova D, Arnoldner MA, Kurz H, Janik S, Brunner PM, Knerer-Schally B, Weninger W, Griss J, Ristl R, Schneider S, Bangert C: „Omalizumab-induced aspirin tolerance in N-ERD patients is independent of atopic sensitization.“ J Allergy Clin Immunol Pract. 2022 Feb;10(2):506-516.e6.
  • Rindler K, Jonak C, Alkon N, Thaler FM, Kurz H, Shaw LE, Stingl G, Weninger W, Halbritter F, Bauer WM, Farlik M, Brunner PM: „Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma“, Mol Cancer, 2021 Sep 28;20(1):124. doi: 10.1186/s12943-021-01419-2.
  • Alkon N, Bauer W, Krausgruber T, Goh I, Griss J, Nguyen V, Reininger B, Bangert C, Staud C, Brunner PM, Bock C, Haniffa M, Stingl G.: „Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis.“ J Allergy Clin Immunol. 2022 Feb;149(2):624-639.
  • Robson PM, Kaufman A, Pruzan A, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Brunner PM, Guttman E, Fayad ZA, Mani V: „Scan-rescan measurement repeatability of 18F-FDG PET/MR imaging of vascular inflammation”, J Nucl Cardiol. 2022 Aug;29(4):1660-1670.

2021

  • Bauer M, Lackner E, Matzneller P, Al Jalili V, pajenda S, Ling V, Böhler C, Braun W, Braun R, Boesch M, Brunner PM, Zeitlinger M: „Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis”, Front Med (Lausanne). 2021 Jul 16;8:712511.
  • Brunner PM, Conrad C, Vender R, Grond S, Schuster C, Patel H, Xu W, Carrascosa Carrillo JM.: „Integrated safety analysis of treatment-emergent eczematous reactions in patients with moderate-to-severe psoriasis treated with ixekizumab, etanercept and ustekinumab.“ Br J Dermatol. 2021 Oct;185(4):865-867.
  • Jonak C, Alkon N, Rindler K, Rojahn TB, Shaw LE, Porkert S, Weninger W, Trautinger F, Stingl G, Tschandl P, Cerroni L, Farlik M, Brunner PM: „Single-cell RNAseq profiling in a patient with discordant primary cutaneous B and T cell lymphoma reveals micromilieu-driven immune skewing.“ Br J Dermatol. 2021 Nov;185(5):1013-1025.
  • Rindler K, Bauer WM, Jonak C, Wielscher M, Shaw LE, Rojahn TB, Thaler FM, Porkert S, Simonitsch-Klupp I, Weninger W, Mayerhoefer ME, Farlik M, Brunner PM: „Single-cell RNA sequencing reveals tissue compartment-specific plasticity of mycosis fungoides tumor cells“ Front Immunol. 2021 Apr 21;12:666935.
  • Novoszel P, Holcmann M, Stulnig G, De Sa Fernandes C, Zyulina V, Borek I, Linder M, Bogusch A, Drobits B, Bauer T, Tam-Amersdorfer C, Brunner PM, Stary G, Bakiri L, Wagner EF, Strobl H, Sibilia M: “Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells” EMBO Mol Med. 2021 Apr 9;13(4):e12409.
  • Frew J, Magnani L, Suarez-Farinas M, Garcet S, Brunner PM, Czarnowicki T, Kim J, Bottomley C, Finney R, Cueto I, Fuentes-Duculan J, Ohmatsu H, Lentini T, Yanofsky V, Krueger JG, Guttman-Yassky E, Gareau D: “The Erythema Q-score, an Imaging Biomarker for Redness in Skin Inflammation.” Exp Dermatol. 2021 Mar;30(3):377-383.
  • Rindler K, Krausgruber T, Thaler FM, Alkon N, Bangert C, Kurz H, Fortelny N, Rojahn TB, Jonak C, Griss J, Bock C, Brunner PM: “Spontaneously resolved atopic dermatitis shows melanocyte and immune cell activation distinct from healthy control skin.” Front Immunol. 2021 Feb 24;12:630892.
  • Bangert C, Rindler K, Krausgruber T, Alkon N, Thaler FM, Kurz H, Ayub T, Demirtas D, Fortelny N, Vorstandlechner V, Bauer WM, Quint T, Mildner M, Jonak C, Elbe-Bürger A, Griss J, Bock C, Brunner PM: „Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4Rα blockade.“ Sci Immunol. 2021 Jan 22;6(55):eabe2749.

2020

  • Rojahn TB, Vorstandlechner V, Krausgruber T, Bauer WM, Alkon N, Bangert C, Thaler FM, Sadeghyar F, Fortelny N, Gernedl V, Rindler K, Elbe-Bürger A, Bock C, Mildner M, Brunner PM: “Single-cell transcriptomics combined with interstitial fluid proteomics defines cell-type-specific immune regulation in atopic dermatitis.” J Allergy Clin Immunol. 2020 Nov;146(5):1056-1069.
  • Ungar B, Pavel AB, Robson PM, Kaufman A, Pruzan A, Brunner P, Kaushik S, Krueger JG, Lebwohl MG, Mani V, Fayad ZA, Guttman-Yassky E: “A preliminary 18F-FDG-PET/MRI study shows increased vascular inflammation in moderate-to-severe atopic dermatitis” J Allergy Clin Immunol Pract 2020 Nov-Dec 2020;8(10):3500-3506.
  • Quint T, Brunner PM, Sinz C, Steiner I, Ristl R, Vigl K, Kimeswenger S, Neubauer K, Pirkhammer D, Zikeli M, Hoetzenecker W, Reider N, Bangert C. Dupilumab for the Treatment of Atopic Dermatitis in an Austrian Cohort-Real-Life Data Shows Rosacea-Like Folliculitis. J Clin Med. 2020 Apr 24;9(4).

Review Articles and Comments

  • Brunner PM: “Facing eczema – Non-invasive transcriptomic analyses from sebum of children with mild-to-moderate atopic dermatitis”, J Eur Acad Dermatol Venereol. 2022 Sep;36(9):1402-1403.
  • Chennareddy S, Brunner PM: „Sphingolipids in viral skin superinfection: friend or foe?“ J Allergy Clin Immunol. 2022 Oct 11:S0091-6749(22)01340-9. doi: 10.1016/j.jaci.2022.09.031. Online ahead of print.
  • Jonak C, Brunner PM: “Blood will tell: profiling Sézary syndrome”, Blood. 2021 Dec 16;138(24):2450-2451.
  • Untersmayr E, Förster-Waldl E, Bonelli M, Boztug K, Brunner PM, Eiwegger T, Eller K, Göschl L, Grabmeier-Pfistershammer K, Hötzenecker W, Jordakieva G, Moschen AR, Pfaller B, Pickl W, Reinisch W, Wiedermann U, Klimek L, Bergmann KC, Brehler R, Pfützner W, Novak N, Merk H, Rabe U, Schlenter W, Ring J, Wehrmann W, Mülleneisen N, Wrede H, Fuchs T, Jensen-Jarolim E. „Immunologically relevant aspects of the new COVID-19 vaccines-an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper.“ Allergo J. 2021;30(5):34-47.
  • Jonak C, Tittes J, Brunner PM, Guenova E: „Mycosis fungoides and Sézary syndrome”, J Dtsch Dermatol Ges. 2021 Sep;19(9):1307-1334.
  • Vieyra-Garcia PA, Brunner P, Blunder S, Hoetzenecker W, Bauer J, Wally V.: „6. Wissenschaftstage der Österreichischen Gesellschaft für Dermatologie und Venerologie – ÖGDV Forschungstage.“ J Dtsch Dermatol Ges. 2021 Oct;19(10):1550-1551.
  • Brunner PM, Jonak C, Knobler R.: “Recent advances in understanding and managing cutaneous T-cell lymphomas.” F1000Res. 2020 May 5;9:F1000 Faculty Rev-331.